CN Patent

CN113069438A — 含有二甲双胍和安非他酮的药物组合物及其用途

Assigned to Shenyang Xinrui Pharmaceutical Co ltd · Expires 2021-07-06 · 5y expired

What this patent protects

本发明涉及一种含有二甲双胍和安非他酮的药物组合物及其用途。该药物组合物与二甲双胍单方药物相比，疗效更强，安全性更高。该组合物可用于降低血糖、治疗糖尿病、预防糖尿病并发症和减重。

USPTO Abstract

本发明涉及一种含有二甲双胍和安非他酮的药物组合物及其用途。该药物组合物与二甲双胍单方药物相比，疗效更强，安全性更高。该组合物可用于降低血糖、治疗糖尿病、预防糖尿病并发症和减重。

Drugs covered by this patent

Patent Metadata

Patent number: CN113069438A
Jurisdiction: CN
Classification: —
Expires: 2021-07-06
Drug substance claim: No
Drug product claim: No
Assignee: Shenyang Xinrui Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.